These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 35409263)

  • 1. PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis.
    Paolini C; Agarbati S; Benfaremo D; Mozzicafreddo M; Svegliati S; Moroncini G
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of evidence of stimulatory autoantibodies to platelet-derived growth factor receptor in patients with systemic sclerosis.
    Classen JF; Henrohn D; Rorsman F; Lennartsson J; Lauwerys BR; Wikström G; Rorsman C; Lenglez S; Franck-Larsson K; Tomasi JP; Kämpe O; Vanthuyne M; Houssiau FA; Demoulin JB
    Arthritis Rheum; 2009 Apr; 60(4):1137-44. PubMed ID: 19333949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA interference against platelet-derived growth factor receptor α mRNA inhibits fibroblast transdifferentiation in skin lesions of patients with systemic sclerosis.
    Liu T; Zhang J; Zhang J; Mu X; Su H; Hu X; Liu W; Zhao E; Li W
    PLoS One; 2013; 8(4):e60414. PubMed ID: 23577108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of PDGF-A/PDGFR-α in proliferation and transdifferentiation of fibroblasts from skin lesions of patients with systemic sclerosis].
    Liu T; Zhang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Apr; 32(4):496-501. PubMed ID: 22543129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis.
    Baroni SS; Santillo M; Bevilacqua F; Luchetti M; Spadoni T; Mancini M; Fraticelli P; Sambo P; Funaro A; Kazlauskas A; Avvedimento EV; Gabrielli A
    N Engl J Med; 2006 Jun; 354(25):2667-76. PubMed ID: 16790699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-cell depletion therapy in patients with diffuse systemic sclerosis associates with a significant decrease in PDGFR expression and activation in spindle-like cells in the skin.
    Daoussis D; Tsamandas AC; Liossis SN; Antonopoulos I; Karatza E; Yiannopoulos G; Andonopoulos AP
    Arthritis Res Ther; 2012 Jun; 14(3):R145. PubMed ID: 22697462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of detection of agonist activity by antibodies to platelet-derived growth factor receptor alpha in a subset of normal and systemic sclerosis patient sera.
    Loizos N; Lariccia L; Weiner J; Griffith H; Boin F; Hummers L; Wigley F; Kussie P
    Arthritis Rheum; 2009 Apr; 60(4):1145-51. PubMed ID: 19333919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of PDGF Receptors by Crenolanib Has Therapeutic Effect in Patient Fibroblasts and in Preclinical Models of Systemic Sclerosis.
    Makino K; Makino T; Stawski L; Mantero JC; Lafyatis R; Simms R; Trojanowska M
    J Invest Dermatol; 2017 Aug; 137(8):1671-1681. PubMed ID: 28433542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of platelet-derived growth factor signaling in healing myocardial infarcts.
    Zymek P; Bujak M; Chatila K; Cieslak A; Thakker G; Entman ML; Frangogiannis NG
    J Am Coll Cardiol; 2006 Dec; 48(11):2315-23. PubMed ID: 17161265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonistic antibodies in systemic sclerosis.
    Moroncini G; Svegliati Baroni S; Gabrielli A
    Immunol Lett; 2018 Mar; 195():83-87. PubMed ID: 29032187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of PDGF in fibrosis and scleroderma: recent insights from animal models and potential therapeutic opportunities.
    Iwayama T; Olson LE
    Curr Rheumatol Rep; 2013 Feb; 15(2):304. PubMed ID: 23307576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease.
    Svegliati S; Olivieri A; Campelli N; Luchetti M; Poloni A; Trappolini S; Moroncini G; Bacigalupo A; Leoni P; Avvedimento EV; Gabrielli A
    Blood; 2007 Jul; 110(1):237-41. PubMed ID: 17363728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future treatments in systemic sclerosis.
    Asano Y
    J Dermatol; 2010 Jan; 37(1):54-70. PubMed ID: 20175840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between platelet-derived growth factor signaling pathway and inflammation in desoxycorticosterone-induced salt-sensitive hypertensive rats with myocardial fibrosis.
    Fan B; Ma L; Li Q; Wang L; Zhou J; Wu J
    Int J Clin Exp Pathol; 2013; 6(11):2468-75. PubMed ID: 24228109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oxidative stress on protein tyrosine phosphatase 1B in scleroderma dermal fibroblasts.
    Tsou PS; Talia NN; Pinney AJ; Kendzicky A; Piera-Velazquez S; Jimenez SA; Seibold JR; Phillips K; Koch AE
    Arthritis Rheum; 2012 Jun; 64(6):1978-89. PubMed ID: 22161819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic sclerosis and localized scleroderma--current concepts and novel targets for therapy.
    Distler O; Cozzio A
    Semin Immunopathol; 2016 Jan; 38(1):87-95. PubMed ID: 26577237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma.
    Ludwicka A; Ohba T; Trojanowska M; Yamakage A; Strange C; Smith EA; Leroy EC; Sutherland S; Silver RM
    J Rheumatol; 1995 Oct; 22(10):1876-83. PubMed ID: 8991985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-derived growth factor and renal disease.
    Nakagawa T; Inoue H; Sasahara M
    Curr Opin Nephrol Hypertens; 2012 Jan; 21(1):80-5. PubMed ID: 22123208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both platelet-derived growth factor receptor (PDGFR)-alpha and PDGFR-beta promote murine fibroblast cell migration.
    Yu J; Moon A; Kim HR
    Biochem Biophys Res Commun; 2001 Apr; 282(3):697-700. PubMed ID: 11401517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach.
    Moroncini G; Cuccioloni M; Mozzicafreddo M; Pozniak KN; Grieco A; Paolini C; Tonnini C; Spadoni T; Svegliati S; Funaro A; Angeletti M; Gabrielli A
    Anal Biochem; 2017 Jul; 528():26-33. PubMed ID: 28450104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.